KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

UiPath (PATH) Gains from Investment Securities: 2020-2025

Historic Gains from Investment Securities for UiPath (PATH) over the last 6 years, with Jan 2025 value amounting to $77.9 million.

  • UiPath's Gains from Investment Securities rose 6.86% to $15.4 million in Q4 2025 from the same period last year, while for Oct 2025 it was $59.2 million, marking a year-over-year decrease of 38.89%. This contributed to the annual value of $77.9 million for FY2025, which is 30.46% down from last year.
  • UiPath's Gains from Investment Securities amounted to $77.9 million in FY2025, which was down 30.46% from $112.1 million recorded in FY2024.
  • In the past 5 years, UiPath's Gains from Investment Securities ranged from a high of $112.1 million in FY2024 and a low of $4.5 million during FY2021.
  • In the last 3 years, UiPath's Gains from Investment Securities had a median value of $77.9 million in 2025 and averaged $87.7 million.
  • Its Gains from Investment Securities has fluctuated over the past 5 years, first soared by 598.34% in 2023, then crashed by 30.46% in 2025.
  • Over the past 5 years, UiPath's Gains from Investment Securities (Yearly) stood at $4.5 million in 2021, then surged by 132.14% to $10.5 million in 2022, then skyrocketed by 598.34% to $73.1 million in 2023, then soared by 53.32% to $112.1 million in 2024, then slumped by 30.46% to $77.9 million in 2025.